RxDoctor Payments Data

George Kurian, MD

Gastroenterology · Glen Burnie, MDNPI 1285663070

Payments from drug & device makers

$2,868in general payments, 2019–2025

Across 164 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$357
  • Johnson & Johnson$241
  • Braintree Laboratories, Inc.$220
  • Nestle Healthcare Nutrition Inc.$191
  • Takeda Pharmaceuticals U.S.A., Inc.$142
  • plus $683 from 13 others

What the payments were for

  • Food & beverage$2,61191%
  • Education$973%
  • Gifts$1606%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,868 in reported general payments places this provider in the 45th percentile of 455 gastroenterology providers in Maryland.

See all gastroenterology providers in Maryland

Medicare billing

Part B allowed, 2024
$74,049
Medicare patients
317
Services billed
534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase12$20,815
CreonLipase/Protease/Amylase15$15,778
MovantikNaloxegol Oxalate17$8,098
Mesalamine24$6,958
Sucralfate34$2,819
ClenpiqSod Picosulf/Mag Ox/Citric Ac16$2,691
Colestipol Hcl12$850
Famotidine32$501
Pantoprazole Sodium41$394
Omeprazole12$329
Metoclopramide Hcl15$249
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl13$180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$1,032$15,77815 claims
Redhill Biopharma Inc.Movantik$22$8,09817 claims
Ferring Pharmaceuticals Inc.Clenpiq$62$2,69116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 455 gastroenterology providers in Maryland.

Other gastroenterology in Glen Burnie

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →